1.5 cm Bethesda III nodule in a 50-year-old — pattern, correction, rescue, extent and follow-up

Examiner notes

Probe six domains: (1) ultrasound pattern with taller-than-wide odds and system trade-offs^[9][12]; (2) Bethesda III at 27% with NIFTP correction (III minus 32% relative)^[15][17]; (3) molecular rescue at 80/85% specific avoiding half of surgery^[18]; (4) lobectomy equivalence with completion trends^[22][25]; (5) ablation omission by IoN with dose already halved^[26][27]; (6) dynamic re-stratification without ablation with Tg cutoffs^[49][52]. Award marks for exact numbers with named papers; deduct for pre-NIFTP tables, reflex total thyroidectomy, routine ablation, static risk estimates, or ignoring the epidemic sentence.

Model dialogue

Why was this biopsied, and what does III mean now? Pattern justified it — taller-than-wide carries OR 11.14 with spongiform/cystic alone avoiding biopsy — and the ATA/ACR choice carries its needle price (51.2 vs 25.8% unnecessary).^[9][12] Bethesda III means 27% pooled malignancy — corrected down by NIFTP reclassification with the largest relative fall (32%) in this very category.^[15][17]

Does molecular testing help her? Yes by randomised numbers: RNA/DNA-RNA specificity 80/85% at 20% prevalence avoids diagnostic surgery in 51/49% — globally halving surgical odds while enriching resected malignancy — so test before scheduling.^[18][20]

How much thyroid goes? Lobectomy-first thinking: matched microcarcinoma ties death and recurrence with complications discounted; completion runs 51.8 to 43.1% post-2015; NIFTP needs no completion — so the lobe with the category consented.^[22][25][21]

Does ablation follow? Not by IoN: 504 low-risk at 97.9 vs 96.3% with 0.5-point noninferiority — with dose already at 1.1 GBq by HiLo (5.9/7.3 at 7 years) — so pT1-T2 N0/Nx skips ablation.^[26][27]

How is she followed? Dynamically: 507 no-ablation patients restratify to 0/1.3/31.6% by response — her excellent response means near-zero structural disease — with 0.3 ng/mL as the recurrence cutoff and 94.2% negative value below threshold.^[49][52][53]

Open and close with the epidemic. Three-quarters of global cases overdiagnosed with the US plateau at 14.6 — so her nodule plan starts with the epidemic sentence and ends with surveillance, not maximalism.^[2][3]